SE403703B - Forfarande for framstellning av s-sulfonerade immunoglobuliner - Google Patents

Forfarande for framstellning av s-sulfonerade immunoglobuliner

Info

Publication number
SE403703B
SE403703B SE7502346A SE7502346A SE403703B SE 403703 B SE403703 B SE 403703B SE 7502346 A SE7502346 A SE 7502346A SE 7502346 A SE7502346 A SE 7502346A SE 403703 B SE403703 B SE 403703B
Authority
SE
Sweden
Prior art keywords
sulphonated
immunoglobulins
procedure
preparation
sulphonated immunoglobulins
Prior art date
Application number
SE7502346A
Other languages
English (en)
Swedish (sv)
Other versions
SE7502346L (sv
Inventor
K Tomibe
Y Masuho
K Matsuzawa
S Ishimoto
K Satake
T Watanabe
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2634174A external-priority patent/JPS5417721B2/ja
Priority claimed from JP7127474A external-priority patent/JPS511630A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of SE7502346L publication Critical patent/SE7502346L/
Publication of SE403703B publication Critical patent/SE403703B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE7502346A 1974-03-08 1975-03-03 Forfarande for framstellning av s-sulfonerade immunoglobuliner SE403703B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2634174A JPS5417721B2 (de) 1974-03-08 1974-03-08
JP7127474A JPS511630A (ja) 1974-06-24 1974-06-24 Jomyakuchushayomenekiguroburinno seizoho

Publications (2)

Publication Number Publication Date
SE7502346L SE7502346L (sv) 1975-09-09
SE403703B true SE403703B (sv) 1978-09-04

Family

ID=26364115

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502346A SE403703B (sv) 1974-03-08 1975-03-03 Forfarande for framstellning av s-sulfonerade immunoglobuliner

Country Status (12)

Country Link
US (1) US4059571A (de)
CA (1) CA1041997A (de)
CH (1) CH614426A5 (de)
DD (1) DD118655A5 (de)
DE (2) DE2508132C3 (de)
DK (1) DK141432B (de)
FR (1) FR2262996B1 (de)
GB (1) GB1497928A (de)
IN (1) IN138636B (de)
NL (1) NL167167C (de)
NO (1) NO144111C (de)
SE (1) SE403703B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658334C3 (de) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
CH644131A5 (en) * 1979-05-23 1984-07-13 Teijin Ltd Process for the preparation of immunogammaglobulin
US4362661A (en) * 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
US4360457A (en) * 1979-08-30 1982-11-23 Teijin Limited S-Sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
JPS56113713A (en) * 1980-02-14 1981-09-07 Chemo Sero Therapeut Res Inst Preparation of immunoglobulin with high content of monomer
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
WO1991017440A1 (en) * 1990-05-07 1991-11-14 Immunomedics, Inc. Improved method for radiolabeling monovalent antibody fragments
SI2236154T1 (en) * 2003-02-10 2018-08-31 Biogen Ma Inc. THE FORM OF IMUNOGLOBULIN AND THE METHOD OF ITS PREPARATION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m

Also Published As

Publication number Publication date
GB1497928A (en) 1978-01-12
NO750768L (de) 1975-09-09
FR2262996A1 (de) 1975-10-03
FR2262996B1 (de) 1982-01-29
US4059571A (en) 1977-11-22
DK141432C (de) 1980-09-15
CA1041997A (en) 1978-11-07
AU7872975A (en) 1976-09-09
DK93475A (de) 1975-09-09
IN138636B (de) 1976-03-06
NL167167C (nl) 1981-11-16
DE2560155C2 (de) 1984-04-26
DE2508132B2 (de) 1980-02-21
DE2508132C3 (de) 1980-10-16
CH614426A5 (de) 1979-11-30
DK141432B (da) 1980-03-17
NO144111B (no) 1981-03-16
DE2508132A1 (de) 1975-09-11
NL167167B (nl) 1981-06-16
SE7502346L (sv) 1975-09-09
NO144111C (no) 1981-06-24
DD118655A5 (de) 1976-03-12
NL7502745A (nl) 1975-09-10

Similar Documents

Publication Publication Date Title
SE399574C (sv) Sett for framstellning av fluffmassa
SE7513085L (sv) Forfarande for framstellning av etrar
SE403703B (sv) Forfarande for framstellning av s-sulfonerade immunoglobuliner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE430895B (sv) Forfarande for kontinuerlig framstellning av cellulosaglykolat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE7513302L (sv) Framstellning av etrar
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7509569L (sv) Framstellning av etrar
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7502346-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7502346-5

Format of ref document f/p: F